DOCSLIB.ORG

CCES Substance Classification Information

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CCES Substance Classification Information 2004 Respecter son sport, c'est se respecter soi-même. Livret de classification Booklet des substances Classification Classification Substance Be true to yourself. Be true to your sport. your to true Be yourself. to true Be 2004 © 2004 Centre canadien pour l’éthique dans le sport (CCES) (CCES) sport le dans l’éthique pour canadien Centre 2004 © Bobsleigh: CP/COA (Mike Ridewood) (Mike CP/COA Bobsleigh: Cyclisme : CP (Kevin Frayer) (Kevin : CP Cyclisme Athlétisme : CP (Anja Niedringhaus) (Anja : CP Athlétisme Ski alpin : CP (Christian Landry) (Christian : CP alpin Ski Photos de la page couverture page la de Photos For further information, please contact: Canadian Centre for Ethics in Sport (CCES) 2197 Riverside Drive, Suite 202 Ottawa, Ontario K1H 7X3 préparation du présent document. présent du préparation ’AMA) de son précieux concours dans la dans concours précieux son de ’AMA) 1-800-672-7775 (Canada-wide) or (613) 521-3340 l ntréal (laboratoire accrédité par accrédité (laboratoire ntréal Fax: (613) 521-3134 Mo ’INRS-Institut Armand-Frappier à Armand-Frappier ’INRS-Institut l General information - [email protected] remercier à également tient CCES Le Substance information - [email protected] leur soutien et leur apport financier. apport leur et soutien leur www.cces.ca pour canadien Patrimoine du ministère Le CCES remercie Sport Canada et le et Canada Sport remercie CCES Le The CCES gratefully acknowledges the www.cces.ca support and financial contribution of Sport Canada and the Department of [email protected] Canadian Heritage. - substances les sur Questions Information général - [email protected] - général Information Télécopieur : (613) 521-3134 (613) : Télécopieur The CCES would like to thank the 521-3340 (613) ou Canada) (au 1-800-672-7775 INRS-Institut Armand-Frappier (WADA-accredited laboratory in Montreal) for their assistance in the 7X3 K1H (Ontario) Ottawa production of this booklet. 202 bureau Riverside, promenade 2197, Centre canadien pour l’éthique dans le sport (CCES) sport le dans l’éthique pour canadien Centre communiquer avec : avec communiquer u lsd esinmns veuillez renseignements, de plus our P Cover Photos Alpine Ski: CP (Christian Landry) Athletics: CP (Anja Niedringhaus) Cycling: CP (Kevin Frayer) Bobsleigh: CP/COA (Mike Ridewood) © 2004 Canadian Centre for Ethics in Sport (CCES) Substance Classification Booklet – 2004 www.cces.ca Helping Athletes Compete Doping-Free The Canadian Centre for Ethics in Sport (CCES) promotes ethical conduct in all aspects of sport in Canada. It is a distinct privilege to be able to contribute to the value of sport in this way. Through its work the CCES seeks to ensure that sport makes a positive contribution to individuals and communities in Canadian society. To truly safeguard the value of sport however, all of us share an obligation to promote ethical values in sport. Together we have a responsibility to ensure that our sport system is one in which all Canadians can share a sense of trust, confidence, respect and pride as we pursue athletic excellence. The CCES is committed to promoting a fair and doping-free sport environment for all Canadian athletes. We believe that athletes compete because they love their sport, they respect the game and they want to achieve excellence. Collectively, Canadian athletes have called on the CCES to provide services and programs to achieve fair and ethical sport. This booklet provides athletes and their support personnel with a complete overview of the 2004 World Anti-Doping Agency (WADA) Prohibited List and its application to the Canadian Anti-Doping Program. The information in this publication is provided for reference purposes only. The prohibited categories and lists of examples in this booklet are subject to change by WADA. WADA may and does make modifications to the Prohibited List periodically. All athletes are responsible for ensuring that they comply with the rules and regulations of competition, which include any sport federation restrictions and the WADA Prohibited List. If you are in doubt about any substance or product avoid its use. The CCES provides information services to any individual or organization seeking to know whether or not a particular substance or method is prohibited for use in sport. Please note, however, that the CCES does not “clear” or “endorse” consumer products for consumption by Canadian athletes. If you are ever unsure or have any questions about a substance, please contact the CCES for further information. i Substance Classification Booklet – 2004 www.cces.ca Table of Contents Permitted Substances . 1 √ The 2004 WADA Prohibited List . 17 x Prohibited Substances . 25 x TUE Therapeutic Use Exemption (TUE) . 35 Supplements . 39 e Some helpful hints: • For suggestions on permitted medications, consult the Permitted Substances list. • When you’ve been prescribed a medication: 1. Verify with your physician or pharmacist that it is not in the Prohibited Substances list. 2. You should always double-check your medication by consulting the Permitted Substances list. • Please be advised that neither the Permitted nor the Prohibited Substances lists include nutritional supplements, vitamins, herbal products, etc. • Still unsure? Contact the CCES at 1-800-672-7775 or [email protected] ii Substance Classification Booklet – 2004 Permitted Substances Permitted Substances It is important to know that most substances are not prohibited and therefore are available if needed to treat a justifiable medical condition. Substances in this category may be √ prescription or non-prescription medications. This list is not complete but is meant to give you some suggestions of what is permitted. Generic medications are often named by the abbreviation of the company followed by the chemical name of the substance. For example: Apo-, Gen-, Lin-, Novo-, Nu-, PMS-, Rho-, Rhoxal, Riva-, Scheinpharm-, and Taro-. For instance, Apo-Salbutamol is salbutamol. Please note: This list should not be taken as a recommendation concerning the relative efficacy of various substances or as a recommendation to use them. There are other permitted substances not listed here. Check with your physician, pharmacist, or the CCES for additional information. This list provides examples of permitted substances in the following categories: Acne Therapy Antispamodics Anaesthetics (local) Antivirals Analgesics/Anti-inflammatories Anxiolytics/Sedatives Antacids Contraceptives Anti-anginals Cough and Cold Preparations Antiarrhythmics Creams/Ointments/Lotions Antiasthmatics/Bronchial Anti- Decongestants inflammatories Eye/Ear Antibiotics/Antibacterials Gastric Ulcer Anticonvulsants Laxatives Antidepressants Lozenges (Throat) Antidiabetics Mania Therapy Antidiarrheals Muscle Relaxant Antifungals Premenstrual Syndrome and Antihistaminics Dysmenorrhea Antihypertensives Sedatives Anti-inflammatories Smoking Cessation Aids Antimigraine Vaginal Antinauseants/Antiemetics Other Various Medications Antiparasitic Anthelmintics Antimalarials Antiprotozoals 1 Substance Classification Booklet – 2004 Permitted Substances ACNE THERAPY Mepivacaine (Carbocaine, Polocaine) Accutane Roche (isotretinoin) Prilocaine (Citanest, Novocain) Acetoxyl (benzoyl peroxide) Prilocaine (Emla cream and patch) √ Adapalene Ropivacaine (Naropin) Benoxyl (benzoyl peroxide) Tetracaine (Ametop, Pontocaine) Benzac (benzoyl peroxide) Tetracaine (Endospray) Benzagel (benzoyl peroxide) Benzamycin (benzoyl peroxide, ANALGESICS/ANTI-INFLAMMATORIES erythromycin) 222 Tablets (ASA, codeine) Benzoyl Peroxide 642 Tablets (propoxyphene) Clindamycin 692 Tablets (propoxyphene, ASA) Clindoxyl (benzoyl peroxide, clindamycin) Abenol (acetaminophen) Dalacin T Topical Solution (clindamycin) Acetaminophen Diane-35 (cyproterone, ethinylestradiol for Acetylsalicylic acid (ASA) females only) Advil (ibuprofen) Differin (adapalene) Alka Seltzer (ASA, sodium bicarbonate, citric Erythromycin acid) Isotretinoin Alka Seltzer Morning Relief ( ASA, caffeine) Isotrex (isotretinoin) Anacin, -Extra Strength (ASA) Meted (salicylic acid, sulfur) Anaprox (naproxen) Minocycline Ansaid (flurbiprofen) Oxyderm (benzoyl peroxide) Apo-Diclo, -SR (diclofenac) Panoxyl (benzoyl peroxide) Apo-diflunisal Pernox (salicylic acid, sulfur) Apo-Etodolac (etodolac) Retisol-A (tretinoin) Apo-Keto, -E, -SR (ketoprofen) Salicylic Acid Apo-Ketorolac Sans-Acne (ethyl alcohol, erythromycin) Apo-Mefenamic Sebulex (salicylic acid, sulfur) Apo-Napro-Na, -DS (naproxen) Solugel (benzoyl peroxide) Apo-Oxaprozin Staticin (erythromycin) Apo-Sulin (sulindac) Stievamycin (erythromycin, tretinoin) Apo-Tenoxicam Sulfur Arthrotec (diclofenac, misoprostol) Tarazotene Asaphen, -EC (ASA) Tazorac (tazarotene) Aspirin, -Coated (ASA) Tetracycline Atasol plain, -8, -15, -30, codeine Tretinoin (acetaminophen) Triclosan Bextra (valdecoxib) Brexidol 20 (piroxicam) ANAESTHETICS (LOCAL) Celebrex (celecoxib) Articaine (Astracaine, Pontocaine) Coated Aspirin (ASA) Benzocaine (Endospray) Codeine Benzocaine (Auralgan, Anbesol) Codeine Contin Bupivacaine (Marcaine, Sensorcaine) Codeine Phosphate Chloroprocaine (Nesacaine-CE) Darvon-N (propoxyphene) Lidocaine (Xylocaine) Daypro (oxaprozin) Lidocaine (Emla cream and patch) Disalcid (salsalate) 2 Substance Classification Booklet – 2004 Permitted Substances Emtec-30 (acetaminophen, codeine) Ratio-Benzydamine Entrophen (ASA) Ratio-Codeine Exdol-8, -15, -30 (acetaminophen, codeine) Ratio-Flurbiprofen Feldene (piroxicam) Ratio-Indomethacin √ Fexicam (piroxicam) Ratio-Lenoltec N˚1, 2 & 3 (acetaminophen, Fiorinal (ASA, butalbital,
Load more

Recommended publications
  • AO-Klasifikácia Faktúr →Zlomeniny
    AO-klasifikácia faktúr →zlomeniny. AOP-syndróm – skr. syndroma adipositas–oligomenorrhoea–parotis. aorta – [g. aorté srdcovnica] srdcovnica. Začína sa z ľavej komory a vystupuje kraniálne aţ do výšky 2. pravého sternokostálneho kĺbu ako aorta ascendens, pokračovaním je oblúk arcus aortae, aorta descendens, aorta thoracia a aorta abdominalis. Aorta ascendens – začína sa v ľavej komore nad polmesiačikovitými chlopňami a skoro celá sa nachádza v perikarde. Je dlhá asi 4 – 5 cm, jej priemer je 22 – 30 mm. Ihneď nad chlop-ňami je následkom spätných nárazov krvi mierne vydutá do tzv. sinus aortae, výraznejšie u starších osôb. Oddiely a. obsahujúce sinus aortae sa nazývajú bulbus aortae. U starších osôb býva následkom nárazov krvi širší aj koncový úsek vzostupnej a. pred jej prechodom do oblúka, tzv. sinus maximus (quartus) aortae. Tu býva u starších osôb a. často rozširená. A. ascendens, ako aj začiatok arcus aortae majú špeciálne vasa vasorum pochádzajúce z vencovitých tepien (aa. cardiaortales). Tento úsek osobitne patogeneticky rizikový. Začiatok aorta ascendens je ešte obalený vo vagina serosa arteriarum, kt. tvorí na ventrálnom obvode a. priečnu krkvu podloţenú subseróznym tukovým väzivom (Concatova-Bacceli tuková krkva). Vnútri vagina arteriarum je aorta ascendens a začiatrok a. pulmonalis spojené tuhým väzivom (vincula aortae Rindfleischi). Výstup aorta ascendens kryje spredu začiatok a. pulmonalis, ventrálne a vpravo je auricula dextra, dorzálne je uloţený r. dexter a. pulmonalis. Kraniálne vpravo od a. je v. cava superior, vľavo kmeň a. pulmonalis. Z ventrálneho a ľavého sinus aortae sa začína a. coronaria cordis dextra et sinistra. Aorta ascendens a arcus aortae Arcus aortae – je dlhý asi 6 cm, začína sa za sternom vo výške úponu 2.
    [Show full text]
  • UFC PROHIBITED LIST Effective June 1, 2021 the UFC PROHIBITED LIST
    UFC PROHIBITED LIST Effective June 1, 2021 THE UFC PROHIBITED LIST UFC PROHIBITED LIST Effective June 1, 2021 PART 1. Except as provided otherwise in PART 2 below, the UFC Prohibited List shall incorporate the most current Prohibited List published by WADA, as well as any WADA Technical Documents establishing decision limits or reporting levels, and, unless otherwise modified by the UFC Prohibited List or the UFC Anti-Doping Policy, Prohibited Substances, Prohibited Methods, Specified or Non-Specified Substances and Specified or Non-Specified Methods shall be as identified as such on the WADA Prohibited List or WADA Technical Documents. PART 2. Notwithstanding the WADA Prohibited List and any otherwise applicable WADA Technical Documents, the following modifications shall be in full force and effect: 1. Decision Concentration Levels. Adverse Analytical Findings reported at a concentration below the following Decision Concentration Levels shall be managed by USADA as Atypical Findings. • Cannabinoids: natural or synthetic delta-9-tetrahydrocannabinol (THC) or Cannabimimetics (e.g., “Spice,” JWH-018, JWH-073, HU-210): any level • Clomiphene: 0.1 ng/mL1 • Dehydrochloromethyltestosterone (DHCMT) long-term metabolite (M3): 0.1 ng/mL • Selective Androgen Receptor Modulators (SARMs): 0.1 ng/mL2 • GW-1516 (GW-501516) metabolites: 0.1 ng/mL • Epitrenbolone (Trenbolone metabolite): 0.2 ng/mL 2. SARMs/GW-1516: Adverse Analytical Findings reported at a concentration at or above the applicable Decision Concentration Level but under 1 ng/mL shall be managed by USADA as Specified Substances. 3. Higenamine: Higenamine shall be a Prohibited Substance under the UFC Anti-Doping Policy only In-Competition (and not Out-of- Competition).
    [Show full text]
  • Doping Control of Athletes
    trends in analytical chemistry, vol. 7, no. IO, I988 375 trends Doping control of athletes E. G. de Jong*, I?. A. A. Maes and The definition of the Council of Europe for doping J. M. van Rossum is2: Utrecht, Netherlands ‘The administration to or the use by a healthy indi- vidual in any way of compounds which are not natu- History ral to the organism or the use of physiological com- The origin of the word doping is not certain. It first pounds in abnormal doses or in an abnormal way appeared in the English dictionaries at the end of the with the only purpose to artificially and dishonestly nineteenth century. The first reference to the use of influence the performance of this person during doping by athletes was in 1864 during swimming competition.’ competitions that were held in the canals of Amster- Another possible definition is: dam. The use of what is known as a ‘speedball’, a ‘The use of compounds which are not synthesized mixture of heroine and cocaine, by cyclists was de- by the human body or the use of endogenous com- scribed in 1869. In 1904 the Russian chemist pounds in excessive doses with the aim to improve Bukowski was able to identify some alkaloids in the performance in sport competitions.’ saliva of horses’. A simpler definition is: Australia was the first country to take measures ‘The use of forbidden drugs. ’ against doping in sports in 1962, and England fol- The last definition can only be used when we have lowed with the drugs bill in 1964.
    [Show full text]
  • Southern Africa Pga Tour Npc Anti-Doping Program Guide
    SOUTHERN AFRICA PGA TOUR NPC (Association Incorporated under Section 21) ANTI-DOPING PROGRAM GUIDE 2018 Sunshine Tour Anti-Doping Program Guide 2018 Page 1 Contents Page Section 1 Player Guide to the Anti-Doping Program 3 Section 2 Player Guide to Prohibited Substances 7 Section 3 Sunshine Tour Anti-Doping Program 14 Section 4 Anti-Doping Program Definitions 25 Section 5 Sunshine Tour List of Prohibited Substances and Methods 28 Section 6 Therapeutic Use Exemption Declaration & Application 36 Section 7 Player Resources 36 Sunshine Tour Anti-Doping Program Guide 2018 Page 2 SECTION 1 PLAYER GUIDE TO THE SUNSHINE TOUR ANTI DOPING PROGRAM Who is covered by the Sunshine Tour’s Anti-Doping Program? The anti-doping program (the “Program”) was developed in co-operation with the South African Institute for Drug-Free Sport (“SAIDS”) to protect the integrity that is inherent in the sport of golf and to ensure the health and safety of all players. SAIDS was established as a statutory body by the South African Institute for Drug-Free Sport Act no. 14 of 1997 as the independent National Anti-Doping Organisation for South Africa. The SUNSHINE TOUR recognises the independence and jurisdiction of SAIDS. All SUNSHINE TOUR members and BIG EASY TOUR members are bound by the Program. Additionally, any player who participates in a SUNSHINE TOUR co-sanctioned, sanctioned, approved or coordinated tournament is bound by the Program. What substances and methods are prohibited? The World Anti-Doping Agency (WADA) List of Prohibited Substances and Methods (the “List”), in force at the time, defines what is prohibited and the SUNSHINE TOUR List of Prohibited Substances and Methods is based on the List.
    [Show full text]
  • Systematic Evaluation of 1-Chlorobutane for Liquid-Liquid Extraction of Drugs U
    Systematic evaluation of 1-chlorobutane for liquid-liquid extraction of drugs U. Demme1*, J. Becker2, H. Bussemas3, T. Daldrup4, F. Erdmann5, M. Erkens6, P.X. Iten7, H. Käferstein8, K.J. Lusthof9, H.J. Magerl10, L.v. Meyer11, A. Reiter12, G. Rochholz13, A. Schmoldt14, E. Schneider15, H.W. Schütz13, T. Stimpfl16, F. Tarbah17, J. Teske18, W. Vycudilik16, J.P. Weller18, W. Weinmann19 *On behalf of the “Workgroup Extraction“ of the GTFCh (Society of Toxicological and Forensic Chemistry, Germany) Institutes of Forensic Medicine of 1Jena, 2Mainz, 4Duesseldorf, 5Giessen, 7Zuerich (CH), 8Cologne, 10Wuerzburg, 11Munich, 12Luebeck, 13Kiel, 14Hamburg, 16Vienna (A), 18Hannover, 19Freiburg and 3Praxis Labormedizin Dortmund, 6Clin.-Chem. Central Laboratory, Aachen, 9Nat. For. Inst., Den Haag (NL), 15LKA Baden-Wuerttemberg, Stuttgart 17Dubai Police Dept. Introduction In systematic toxicological analysis (STA), chromatographic Experimental Buffer solutions (pH 9) were obtained by dissolving 10 g methods are widely used for the detection of drugs and other organic toxic substances in Na2HPO4 (VWR) in one liter of distilled water. 1-chlorobutane and methanol (analytical biological materials, such as blood, plasma, urine, hair and tissue samples. In most cases grade) were obtained from VWR International (Darmstadt, Germany). Drugs were the applied analytical methods like gas chromatography-mass spectrometry (GC/MS), purchased as pure compounds or as salts from chemical suppliers (Sigma high performance liquid chromatography with diode-array detection (HPLC/DAD), Deissenhofen/Germany and others) or from the pharmaceutical manufacturers and were HPLC/mass spectrometry (LC/MS), or thin-layer chromatography with remission first dissolved in methanol to achieve a concentration of 1 mg/mL. In some instances the spectroscopy (TLC/UV), require sample preparation by extraction prior to analysis.
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • Anti-Doping Manual Revised Dec. 2018
    PGA TOUR Anti-Doping Program Manual REVISED DECEMBER 2018 Table of Contents How To Use This Manual .......................................................................................................................................................2 SECTION 1: Player Guide To Anti-Doping ...........................................................................................................................3 Who is covered by the Anti-Doping Program .........................................................................................................3 What substances and methods are banned ..........................................................................................................3 Am I liable for a prohibited substance in my body even if I did not intend to take the substance ........................3 What should players know about nutritional and health products ...................................................................3 Are there supplements that have been tested/certified as free from banned substances ........................3 What about medical treatment.................................................................................................................................4 What medications are permitted .............................................................................................................................4 Who conducts the testing and who will be tested ................................................................................................4 What are the steps in
    [Show full text]
  • Pharmacology of Stimulants Prohibited by the World Anti-Doping Agency (WADA)
    British Journal of Pharmacology (2008) 154, 606–622 & 2008 Nature Publishing Group All rights reserved 0007– 1188/08 $30.00 www.brjpharmacol.org REVIEW Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA) JR Docherty Department of Physiology, Royal College of Surgeons in Ireland, Dublin, Ireland This review examines the pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA). Stimulants that increase alertness/reduce fatigue or activate the cardiovascular system can include drugs like ephedrine available in many over- the-counter medicines. Others such as amphetamines, cocaine and hallucinogenic drugs, available on prescription or illegally, can modify mood. A total of 62 stimulants (61 chemical entities) are listed in the WADA List, prohibited in competition. Athletes may have stimulants in their body for one of three main reasons: inadvertent consumption in a propriety medicine; deliberate consumption for misuse as a recreational drug and deliberate consumption to enhance performance. The majority of stimulants on the list act on the monoaminergic systems: adrenergic (sympathetic, transmitter noradrenaline), dopaminergic (transmitter dopamine) and serotonergic (transmitter serotonin, 5-HT). Sympathomimetic describes agents, which mimic sympathetic responses, and dopaminomimetic and serotoninomimetic can be used to describe actions on the dopamine and serotonin systems. However, many agents act to mimic more than one of these monoamines, so that a collective term of monoaminomimetic may be useful. Monoaminomimietic actions of stimulants can include blockade of re-uptake of neurotransmitter, indirect release of neurotransmitter, direct activation of monoaminergic receptors. Many of the stimulants are amphetamines or amphetamine derivatives, including agents with abuse potential as recreational drugs.
    [Show full text]
  • 2019 Prohibited List
    THE WORLD ANTI-DOPING CODE INTERNATIONAL STANDARD PROHIBITED LIST JANUARY 2019 The official text of the Prohibited List shall be maintained by WADA and shall be published in English and French. In the event of any conflict between the English and French versions, the English version shall prevail. This List shall come into effect on 1 January 2019 SUBSTANCES & METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OF-COMPETITION) IN ACCORDANCE WITH ARTICLE 4.2.2 OF THE WORLD ANTI-DOPING CODE, ALL PROHIBITED SUBSTANCES SHALL BE CONSIDERED AS “SPECIFIED SUBSTANCES” EXCEPT SUBSTANCES IN CLASSES S1, S2, S4.4, S4.5, S6.A, AND PROHIBITED METHODS M1, M2 AND M3. PROHIBITED SUBSTANCES NON-APPROVED SUBSTANCES Mestanolone; S0 Mesterolone; Any pharmacological substance which is not Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien- addressed by any of the subsequent sections of the 3-one); List and with no current approval by any governmental Metenolone; regulatory health authority for human therapeutic use Methandriol; (e.g. drugs under pre-clinical or clinical development Methasterone (17β-hydroxy-2α,17α-dimethyl-5α- or discontinued, designer drugs, substances approved androstan-3-one); only for veterinary use) is prohibited at all times. Methyldienolone (17β-hydroxy-17α-methylestra-4,9-dien- 3-one); ANABOLIC AGENTS Methyl-1-testosterone (17β-hydroxy-17α-methyl-5α- S1 androst-1-en-3-one); Anabolic agents are prohibited. Methylnortestosterone (17β-hydroxy-17α-methylestr-4-en- 3-one); 1. ANABOLIC ANDROGENIC STEROIDS (AAS) Methyltestosterone; a. Exogenous*
    [Show full text]
  • Stembook 2018.Pdf
    The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 WHO/EMP/RHT/TSN/2018.1 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances. Geneva: World Health Organization; 2018 (WHO/EMP/RHT/TSN/2018.1). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.
    [Show full text]
  • A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
    A abacavir abacavirum abakaviiri abagovomab abagovomabum abagovomabi abamectin abamectinum abamektiini abametapir abametapirum abametapiiri abanoquil abanoquilum abanokiili abaperidone abaperidonum abaperidoni abarelix abarelixum abareliksi abatacept abataceptum abatasepti abciximab abciximabum absiksimabi abecarnil abecarnilum abekarniili abediterol abediterolum abediteroli abetimus abetimusum abetimuusi abexinostat abexinostatum abeksinostaatti abicipar pegol abiciparum pegolum abisipaaripegoli abiraterone abirateronum abirateroni abitesartan abitesartanum abitesartaani ablukast ablukastum ablukasti abrilumab abrilumabum abrilumabi abrineurin abrineurinum abrineuriini abunidazol abunidazolum abunidatsoli acadesine acadesinum akadesiini acamprosate acamprosatum akamprosaatti acarbose acarbosum akarboosi acebrochol acebrocholum asebrokoli aceburic acid acidum aceburicum asebuurihappo acebutolol acebutololum asebutololi acecainide acecainidum asekainidi acecarbromal acecarbromalum asekarbromaali aceclidine aceclidinum aseklidiini aceclofenac aceclofenacum aseklofenaakki acedapsone acedapsonum asedapsoni acediasulfone sodium acediasulfonum natricum asediasulfoninatrium acefluranol acefluranolum asefluranoli acefurtiamine acefurtiaminum asefurtiamiini acefylline clofibrol acefyllinum clofibrolum asefylliiniklofibroli acefylline piperazine acefyllinum piperazinum asefylliinipiperatsiini aceglatone aceglatonum aseglatoni aceglutamide aceglutamidum aseglutamidi acemannan acemannanum asemannaani acemetacin acemetacinum asemetasiini aceneuramic
    [Show full text]
  • 2150 Stimulants and Anorectics Mental Impairment
    2150 Stimulants and Anorectics Mental impairment. References. Bass; B-bombs; Beans; Bennie; Bennies; Benny and the Jets; 1. Poitrenaud J, et al. Almitrine-raubasine and cognitive impair- Bens; Benz; Benzedrine; Benzidrine; Berick; Billy; Billy Whizz; ment in the elderly: results of a 6-month controlled multicenter Biphetamine; Bippies; Black beauties; Black birds; Black bomb- study. Clin Neuropharmacol 1990; 13 (suppl 3): S100–S108. ers; Black cadillacs; Black hollies; Black mollies; Black and 2. Poitrenaud J, et al. Time course of age-associated memory im- white; Blacks; Blue belly; Blue boy; Blue mollies; Bolt; Bombi- H pairment in 8037 patients treated with Duxil for 6 months. Rev do; Bombita; Bombitas; Boostant; Bottles; Brain pills; Brain N Geriatr 1994; 19: 531–8. ticklers; Brownies; Browns; Bumblebees; Candy; Cartwheels; 3. Poitrenaud J, et al. Memory disorders in 8037 elderly patients Chalk; Chicken powder; Chocolate; Christina; Christmas tree; CH with age-associated memory impairment: multicenter trial with Clear rocks; Coast to coast; Coasts to coasts; Colorado Rockies; 3 a 6-month follow-up under almitrine-raubasine. Eur Neurol 1995; 35 (suppl 1): 43–6. Co-pilot; Crank; Crisscross; Croke; Cross tops; Cross-tops; N 4. Allain H, Bentue-Ferrer D. Clinical efficacy of almitrine-rauba- Crossroads; Crystal; Crystal methadrine; Debs; Dex; Dexadrine; sine: an overview. Eur Neurol 1998; 39 (suppl 1): 39–44. Dexedrine; Dexies; Diamonds; Diet Coke; Diet pills; Dolls; Dominoes; Double cross; Drivers; Eve; Eye opener; Eye open- Profile Respiratory system disorders. Respiratory stimulants (such ers; Fast; Fast balls; Fastin; Fives; Fly Boys; Football; Footballs; Amfetaminil is a central stimulant that has been given orally in as almitrine) have a limited and short-term role in acute respira- Forwards; French blue; French blues; Gaggler; Gas; GB’s; the treatment of narcolepsy.
    [Show full text]